WHO has expressed interest in the widespread use of the Sputnik V vaccine

WHO has expressed interest in the widespread use of the Sputnik V vaccine

Director-General of the World Health Organization (WHO) Tedros Adanom Gebreyesus at a meeting with Russian Deputy Foreign Minister Sergei Vershinin in Geneva, expressed interest in the widespread use of the vaccine against coronavirus Sputnik V.

The Foreign Ministry reported that the head of the organization praised Russia’s contribution to multilateral cooperation under the auspices of the WHO, including global efforts to combat the pandemic coronavirus infection. “The organization is interested in the wide use of the Russian Sputnik-V vaccine and other responsible drugs for preventing coronavirus infection to help countries in need, including through international mechanisms,” the office said.

In March, Hans Kluge, Director of the WHO Regional Office for Europe, praised Russia’s fight against the COVID-19 pandemic. “Russia has set the highest bar in coordinating measures at all levels: political, technical, epidemiological, and social. Two other critical elements were the ability to rapidly increase testing, really very massively, and the second was the health care system, the rapid growth of hospital beds,” the WHO spokesman said.

“Sputnik V is the first registered Russian coronavirus vaccine based on adenovirus. The drug is registered in more than 50 countries. Currently, the development of Russian scientists is among the top ten vaccine candidates on the World Health Organization list.

ALSO READ:  Erdogan announces full lockdown in Turkey